These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 14230879)
1. [THROMBOLYTIC THERAPY. CLINICAL TRIALS OF TREATMENT WITH PURIFIED STREPTOKINASE]. ABASTADO M Bull Mem Soc Med Hop Paris; 1964 Jul; 115():941-57. PubMed ID: 14230879 [No Abstract] [Full Text] [Related]
2. [PRESENT STATUS OF THROMBOLYTIC THERAPY]. VAIREL EG; ANTOINE G Sangre (Barc); 1964; 41():441-6. PubMed ID: 14248832 [No Abstract] [Full Text] [Related]
3. [THERAPEUTIC FIBRINOLYSIS. II. STUDIES ON THE EFFICACY OF STREPTOKINASE AND ACTASE IN VIVO]. JUERGENS J Klin Wochenschr; 1964 Jun; 42():539-46. PubMed ID: 14233282 [No Abstract] [Full Text] [Related]
4. THROMBOLYTIC THERAPY. DOUGLAS AS; MCNICOL GP Br Med Bull; 1964 Sep; 20():228-32. PubMed ID: 14209763 [No Abstract] [Full Text] [Related]
5. THROMBOLYTIC THERAPY. DOUGLAS AS; MCNICOL GP Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954 [No Abstract] [Full Text] [Related]
6. THE PRESENT STATUS OF FIBRINOLYTIC THERAPY. CLIFFTON EE Angiology; 1963 Nov; 14():533-41. PubMed ID: 14075024 [No Abstract] [Full Text] [Related]
7. [FIBRINOLYSIS, THROMBOLYSIS AND FIBRINOLYTIC TREATMENT]. STOICHITA M Med Interna (Bucur); 1964 Oct; 16():1163-72. PubMed ID: 14244194 [No Abstract] [Full Text] [Related]
8. [SURGICAL AND THROMBOLYTIC TREATMENT INDICATIONS OF THE ACUTE ARTERIAL OCCLUSION]. SCHMUTZLER R; WAIBEL P; WIDMER LK Schweiz Med Wochenschr; 1965 Jun; 95():831-5. PubMed ID: 14305113 [No Abstract] [Full Text] [Related]
9. THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION. FLETCHER AP; ALKJAERSIG N; SHERRY S; GENTON E; HIRSH J; BACHMANN F J Lab Clin Med; 1965 May; 65():713-31. PubMed ID: 14281368 [No Abstract] [Full Text] [Related]
10. THE ROLE OF FIBRINOLYSIS IN THE TREATMENT OF ARTERIAL THROMBOSIS: EXPERIMENTAL AND CLINICAL ASPECTS. TSAPOGAS MJ Ann R Coll Surg Engl; 1964 May; 34(5):293-313. PubMed ID: 14145330 [No Abstract] [Full Text] [Related]
11. STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD TO OBTAIN THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS. HELLE I; AAS K; GODAL HC Sangre (Barc); 1964; 38():167-74. PubMed ID: 14217607 [No Abstract] [Full Text] [Related]
12. RADIOACTIVE (I-125) HUMAN PLASMA CLOTS FOR ASSAY OF THROMBOLYTIC ACTIVITY. HUME M J Lab Clin Med; 1964 Apr; 63():699-702. PubMed ID: 14155458 [No Abstract] [Full Text] [Related]
13. CURRENT STATUS OF THROMBOLYTIC THERAPY. SHERRY S Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883 [No Abstract] [Full Text] [Related]
14. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE). JAMES DC; BROWSE NL Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065 [No Abstract] [Full Text] [Related]